Search Results for

*

1-2 of 2 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Metformin Therapy and Diabetes Prevention in Adolescents Who Are Obese - FPIN's ...

Nov 1, 2007 - No studies have addressed the question of whether metformin reduces development of diabetes among adolescents who are obese. Metformin treatment in adolescents who are obese can modestly reduce risk factors for type 2 diabetes, including elevated body mass index (BMI), fasting insulin ...

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2007/1101/p1357.html

Is Fluoxetine an Effective Therapy for Weight Loss in Obese Patients? - FPIN's Clinical...

Dec 15, 2003 - Fluoxetine (Prozac) use may result in an average, short-term weight loss of up to 3.3 kg (7 lb, 4 oz) in obese patients, but the longterm effects and maintenance of weight loss after discontinuation of the drug have not been well studied. No evidence concerning other SSRIs was found.

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2003/1215/p2437.html

Page  1

25 50 100 results per page